Of mice and men: The best laid scheme?

Timothy D. Henry; Heidi J. Reich; Andreas M. Zeiher

doi:10.1016/j.jacc.2015.02.035

Of mice and men: The best laid scheme?

Timothy D. Henry
, Heidi J. Reich
, Andreas M. Zeiher

Medicine - Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1435-1437
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	65
Issue number	14
DOIs	https://doi.org/10.1016/j.jacc.2015.02.035
State	Published - Apr 14 2015

Bibliographical note

Funding Information:
Dr. Henry is Principal Investigator with NIH Cardiovascular Cell Therapy Research Network (CCTRN); ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; and ATHENA Trial, Cytori; and is on the Steering Committee with NIH CCTRN; ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; Chart-2, Cardio3 Biosciences; and ATHENA Trial, Cytori. Dr. Zeiher is scientific advisor and co-founder of t2cure. Dr. Reich’s research effort is supported by the TSFRE Braunwald Fellowship.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

CD34
angiogenesis
left ventricular assist device
stem cell

Publisher link

10.1016/j.jacc.2015.02.035

Find It

Find It at U of M Libraries

Cite this

@article{da148f5838bd41298c4133feb142e993,

title = "Of mice and men: The best laid scheme?",

keywords = "CD34, angiogenesis, left ventricular assist device, stem cell",

author = "Henry, \{Timothy D.\} and Reich, \{Heidi J.\} and Zeiher, \{Andreas M.\}",

note = "Funding Information: Dr. Henry is Principal Investigator with NIH Cardiovascular Cell Therapy Research Network (CCTRN); ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; and ATHENA Trial, Cytori; and is on the Steering Committee with NIH CCTRN; ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; Chart-2, Cardio3 Biosciences; and ATHENA Trial, Cytori. Dr. Zeiher is scientific advisor and co-founder of t2cure. Dr. Reich{\textquoteright}s research effort is supported by the TSFRE Braunwald Fellowship. ",

year = "2015",

month = apr,

day = "14",

doi = "10.1016/j.jacc.2015.02.035",

language = "English (US)",

volume = "65",

pages = "1435--1437",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "14",

}

TY - JOUR

T1 - Of mice and men

T2 - The best laid scheme?

AU - Henry, Timothy D.

AU - Reich, Heidi J.

AU - Zeiher, Andreas M.

N1 - Funding Information: Dr. Henry is Principal Investigator with NIH Cardiovascular Cell Therapy Research Network (CCTRN); ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; and ATHENA Trial, Cytori; and is on the Steering Committee with NIH CCTRN; ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; Chart-2, Cardio3 Biosciences; and ATHENA Trial, Cytori. Dr. Zeiher is scientific advisor and co-founder of t2cure. Dr. Reich’s research effort is supported by the TSFRE Braunwald Fellowship.

PY - 2015/4/14

Y1 - 2015/4/14

KW - CD34

KW - angiogenesis

KW - left ventricular assist device

KW - stem cell

UR - https://www.scopus.com/pages/publications/84926357454

UR - https://www.scopus.com/pages/publications/84926357454#tab=citedBy

U2 - 10.1016/j.jacc.2015.02.035

DO - 10.1016/j.jacc.2015.02.035

M3 - Editorial

C2 - 25857909

AN - SCOPUS:84926357454

SN - 0735-1097

VL - 65

SP - 1435

EP - 1437

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 14

ER -

Of mice and men: The best laid scheme?

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Cite this